These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15528711)

  • 1. Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis.
    Chaudry AN; Travers PJ; Yuenger J; Colletta L; Evans P; Zenilman JM; Tummon A
    J Clin Microbiol; 2004 Nov; 42(11):5170-5. PubMed ID: 15528711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nugent and Spiegel criteria for the diagnosis of bacterial vaginosis. Analysis of discordant specimens by the Ison and Hay method].
    Martínez MA; Ovalle A; Gaete AM; Lillo E; de la Fuente F; Araneda F; Villaseca R; Salinas H
    Rev Med Chil; 2011 Jan; 139(1):66-71. PubMed ID: 21526319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel diagnostic test for bacterial vaginosis: 'the electronic nose'.
    Hay P; Tummon A; Ogunfile M; Adebiyi A; Adefowora A
    Int J STD AIDS; 2003 Feb; 14(2):114-8. PubMed ID: 12662390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.
    Sha BE; Chen HY; Wang QJ; Zariffard MR; Cohen MH; Spear GT
    J Clin Microbiol; 2005 Sep; 43(9):4607-12. PubMed ID: 16145114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of Nugent and Amsel criteria for the diagnosis of bacterial vaginosis].
    Navarrete P; Domínguez M; Castro E; Zemelman R
    Rev Med Chil; 2000 Jul; 128(7):767-71. PubMed ID: 11050838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Amsel criteria, Nugent score, culture and two CE-IVD marked quantitative real-time PCRs with microbiota analysis for the diagnosis of bacterial vaginosis.
    van den Munckhof EHA; van Sitter RL; Boers KE; Lamont RF; Te Witt R; le Cessie S; Knetsch CW; van Doorn LJ; Quint WGV; Molijn A; Leverstein-van Hall MA
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):959-966. PubMed ID: 30903536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Indicators of Recurrence of Bacterial Vaginosis.
    Sobel JD; Kaur N; Woznicki NA; Boikov D; Aguin T; Gill G; Akins RA
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of bacterial vaginosis in antenatal women.
    Mathew R; Kalyani J; Bibi R; Mallika M
    Indian J Pathol Microbiol; 2001 Apr; 44(2):113-6. PubMed ID: 11883123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of bacterial vaginosis with high dosage metronidazole and lactic acid].
    Andreeva P; Slavchev B; Kovachev S; Nacheva A; Vacheva R
    Akush Ginekol (Sofiia); 2002; 41(5):36-9. PubMed ID: 12440337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis.
    Hilbert DW; Smith WL; Paulish-Miller TE; Chadwick SG; Toner G; Mordechai E; Adelson ME; Sobel JD; Gygax SE
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):231-42. PubMed ID: 27431434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal microbiome variances in sample groups categorized by clinical criteria of bacterial vaginosis.
    Chen HM; Chang TH; Lin FM; Liang C; Chiu CM; Yang TL; Yang T; Huang CY; Cheng YN; Chang YA; Chang PY; Weng SL
    BMC Genomics; 2018 Dec; 19(Suppl 10):876. PubMed ID: 30598080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole with Lactacyd vaginal gel in bacterial vaginosis.
    Decena DC; Co JT; Manalastas RM; Palaypayon EP; Padolina CS; Sison JM; Dancel LA; Lelis MA
    J Obstet Gynaecol Res; 2006 Apr; 32(2):243-51. PubMed ID: 16594932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis.
    Schwebke JR; Hillier SL; Sobel JD; McGregor JA; Sweet RL
    Obstet Gynecol; 1996 Oct; 88(4 Pt 1):573-6. PubMed ID: 8841221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis.
    Holley RL; Richter HE; Varner RE; Pair L; Schwebke JR
    Sex Transm Dis; 2004 Apr; 31(4):236-8. PubMed ID: 15028938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
    Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
    J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram stain as a relapse predictor of bacterial vaginosis after metronidazole treatment.
    Huang M; Wang JH
    J Microbiol Immunol Infect; 2005 Apr; 38(2):137-40. PubMed ID: 15843859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of modified diagnostic criteria for bacterial vaginosis at peripheral health centres in developing countries.
    Mittal V; Jain A; Pradeep Y
    J Infect Dev Ctries; 2012 May; 6(5):373-7. PubMed ID: 22610702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
    Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.
    Schwebke JR; Desmond RA
    Clin Infect Dis; 2007 Jan; 44(2):213-9. PubMed ID: 17173219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
    Simoes JA; Bahamondes LG; Camargo RP; Alves VM; Zaneveld LJ; Waller DP; Schwartz J; Callahan MM; Mauck CK
    Br J Clin Pharmacol; 2006 Feb; 61(2):211-7. PubMed ID: 16433875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.